Novo Nordisk nach Split WKN: A3EU6F ISIN: DK0062498333 Kürzel: NOV Forum: Aktien User: Coronaprofiteur
“When we launch, we’ll go all in,” Novo’s Executive Vice President for International Operations, Emil Kongshøj Larsen, told CNBC in an interview on Tuesday. “It’s a major opportunity.” $NVO is preparing launch of wegovy pill outside US in several countries. Likely start early to mid Q3 NVO is also shaping the expectations. While they believe wegovy pill can be a big product outside US, they do caution people from expecting the same very steep sales curve. In US wegovy pill is significantly lower prices for start doses than wegovy pen. Even though NVO has not revealed pricing structure outside US yet, it’s clear that we should not expect to see the same repeated outside US. Price will likely be about the same as wegovy pen. And therefore it will not open the market further with lower prices as seen in US. Germany, UK, Norway, Denmark and Spain could likely be in the first wave of launch in Europe $LLY $VKTX
“When we launch, we’ll go all in,” Novo’s Executive Vice President for International Operations, Emil Kongshøj Larsen, told CNBC in an interview on Tuesday. “It’s a major opportunity.” $NVO is preparing launch of wegovy pill outside US in several countries. Likely start early to mid Q3 NVO is also shaping the expectations. While they believe wegovy pill can be a big product outside US, they do caution people from expecting the same very steep sales curve. In US wegovy pill is significantly lower prices for start doses than wegovy pen. Even though NVO has not revealed pricing structure outside US yet, it’s clear that we should not expect to see the same repeated outside US. Price will likely be about the same as wegovy pen. And therefore it will not open the market further with lower prices as seen in US. Germany, UK, Norway, Denmark and Spain could likely be in the first wave of launch in Europe $LLY $VKTX
Mehr zu diesem Wert
|
|
Thema | ||
|---|---|---|---|
| 1 | Novo Nordisk nach Split | ||
| 2 | Novo Nordisk |
|
|
Thema | ||
|---|---|---|---|
| 1 | BYD Hauptdiskussion | -0,58 % | |
| 2 | NEL ASA Hauptdiskussion | -5,93 % | |
| 3 | KRATOS DEFENSE Hauptdiskussion | -1,39 % | |
| 4 | Aktuelles zu Almonty Industries | -0,46 % | |
| 5 | BioNTech Hauptdiskussion | -1,19 % | |
| 6 | Prairie Lithium | ±0,00 % | |
| 7 | ADOBE SYSTEMS Hauptdiskussion | -0,25 % | |
| 8 | Hims & Hers Health Registered (A) Hauptdiskussion | +0,63 % | |
| 9 | XIAOMI CORP. CL.B Hauptdiskussion | -0,35 % | |
| 10 | Palantir | +0,09 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | BYD Hauptdiskussion | -0,58 % | |
| 2 | NEL ASA Hauptdiskussion | -5,93 % | |
| 3 | KRATOS DEFENSE Hauptdiskussion | -1,39 % | |
| 4 | Aktuelles zu Almonty Industries | -0,46 % | |
| 5 | BioNTech Hauptdiskussion | -1,19 % | |
| 6 | Prairie Lithium | ±0,00 % | |
| 7 | ADOBE SYSTEMS Hauptdiskussion | -0,25 % | |
| 8 | Hims & Hers Health Registered (A) Hauptdiskussion | +0,63 % | |
| 9 | XIAOMI CORP. CL.B Hauptdiskussion | -0,35 % | |
| 10 | Palantir | +0,09 % | Alle Diskussionen |